Log in
Enquire now
‌

US Patent 11285214 Pharmaceutical compositions comprising meloxicam

Patent 11285214 was granted and assigned to Axsome Therapeutics on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Axsome Therapeutics
Axsome Therapeutics
Current Assignee
Axsome Therapeutics
Axsome Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11285214
Date of Patent
March 29, 2022
Patent Application Number
17319898
Date Filed
May 13, 2021
Patent Citations
‌
US Patent 10322181 Pharmaceutical compositions comprising meloxicam
‌
US Patent 10702535 Pharmaceutical compositions comprising meloxicam
‌
US Patent 10702602 Pharmaceutical compositions comprising meloxicam
‌
US Patent 10722583 Pharmaceutical compositions comprising meloxicam
‌
US Patent 10729696 Pharmaceutical compositions comprising meloxicam
‌
US Patent 10729697 Pharmaceutical compositions comprising meloxicam
‌
US Patent 10729773 Pharmaceutical compositions comprising meloxicam
‌
US Patent 10729774 Pharmaceutical compositions comprising meloxicam
...
Patent Citations Received
‌
US Patent 11617755 Pharmaceutical compositions comprising meloxicam
0
‌
US Patent 11617756 Pharmaceutical compositions comprising meloxicam
0
‌
US Patent 11628173 Pharmaceutical compositions comprising meloxicam
0
‌
US Patent 11471464 Pharmaceutical compositions comprising meloxicam
‌
US Patent 11471465 Pharmaceutical compositions comprising meloxicam
‌
US Patent 11759522 Pharmaceutical compositions comprising meloxicam
‌
US Patent 11357854 Pharmaceutical compositions comprising meloxicam
‌
US Patent 11801250 Pharmaceutical compositions comprising meloxicam
...
Patent Primary Examiner
‌
Dennis Heyer
CPC Code
‌
A61K 47/02
‌
A61K 9/0053
‌
A61K 31/4439
‌
A61K 9/2009
‌
A61K 45/06
‌
A61K 31/5415
‌
A61K 47/40
‌
C08B 37/0012
...

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a T

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11285214 Pharmaceutical compositions comprising meloxicam

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.